|
1
|
Wang H, Tan G, Dong L, Cheng L, Li K, Wang
Z and Luo H: Circulating MiR-125b as a marker predicting
chemoresistance in breast cancer. PLoS One. 7:e342102012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coates AS, Winer EP, Goldhirsch A, Gelber
RD, Gnant M, Piccart-Gebhart M, Thürlimann B and Senn HJ: Panel
Members: Tailoring therapies-improving the management of early
breast cancer: St Gallen international expert consensus on the
primary therapy of early breast cancer 2015. Ann Oncol.
26:1533–1546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Prat A, Parker JS, Karginova O, Fan C,
Livasy C, Herschkowitz JI, He X and Perou CM: Phenotypic and
molecular characterization of the claudin-low intrinsic subtype of
breast cancer. Breast Cancer Res. 12:R682010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Y, Zhu P, Wang Y, Wei Z, Tao L, Zhu Z,
Sheng X, Wang S, Ruan J, Liu Z, et al: Antimetastatic therapies of
the polysulfide diallyl trisulfide against triple-negative breast
cancer (TNBC) via suppressing MMP2/9 by blocking NF-kB and ERK/MAPK
signaling pathways. PLoS One. 10:e01237812015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gucalp A and Traina TA: Triple-negative
breast cancer: Role of the androgen receptor. Cancer J. 16:62–65.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sandhu S and Garzon R: Potential
applications of microRNAs in cancer diagnosis, prognosis, and
treatment. Semin Oncol. 38:781–787. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs: New biomarkers for diagnosis, prognosis, therapy
prediction and therapeutic tools for breast cancer. Theranostics.
5:1122–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoo B, Kavishwar A, Ross A, Wang P,
Tabassum DP, Polyak K, Barteneva N, Petkova V, Pantazopoulos P,
Tena A, et al: Combining miR-10b-targeted nanotherapy with low-dose
doxorubicin elicits durable regressions of metastatic breast
cancer. Cancer Res. 75:4407–4415. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
De Leeneer K and Claes K: Non coding RNA
molecules as potential biomarkers in breast cancer. Adv Exp Med
Biol. 867:263–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuan Y, Anbalagan D, Lee LH, Samy RP,
Shanmugam MK, Kumar AP, Sethi G, Lobie PE and Lim LH: ANXA1
inhibits miRNA-196a in a negative feedback loop through NF-κB and
c-Myc to reduce breast cancer proliferation. Oncotarget.
7:27007–27020. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoo JO, Kwak SY, An HJ, Bae IH, Park MJ
and Han YH: miR-181b-3p promotes epithelial-mesenchymal transition
in breast cancer cells through Snail stabilization by directly
targeting YWHAG. Biochim Biophys Acta. 1863:1601–1611. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hemmatzadeh M, Mohammadi H, Jadidi-Niaragh
F, Asghari F and Yousefi M: The role of oncomirs in the
pathogenesis and treatment of breast cancer. Biomed Pharmacother.
78:129–139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao ZG, Li JJ, Yao L, Huang YN, Liu YR, Hu
X, Song CG and Shao ZM: High expression of microRNA-454 is
associated with poor prognosis in triple-negative breast cancer.
Oncotarget. 7:64900–64909. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang L, Wei D and Yan F: MicroRNA-145
functions as a tumor suppressor by targeting matrix
metalloproteinase 11 and Rab GTPase family 27a in triple-negative
breast cancer. Cancer Gene Ther. 23:258–265. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Humphries B, Wang Z, Oom AL, Fisher T, Tan
D, Cui Y, Jiang Y and Yang C: MicroRNA-200b targets protein kinase
Cα and suppresses triple-negative breast cancer metastasis.
Carcinogenesis. 35:2254–2263. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Ye ZH, Liang HW, Ren FH, Li P,
Dang YW and Chen G: Down-regulation of miR-146a-5p and its
potential targets in hepatocellular carcinoma validated by a TCGA-
and GEO-based study. FEBS Open Bio. 7:504–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang C, Zhang W, Zhang L, Chen X, Liu F,
Zhang J, Guan S, Sun Y, Chen P, Wang D, et al: miR-146a-5p mediates
epithelial-mesenchymal transition of oesophageal squamous cell
carcinoma via targeting Notch2. Br J Cancer. 115:1548–1554. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li YL, Wang J, Zhang CY, Shen YQ, Wang HM,
Ding L, Gu YC, Lou JT, Zhao XT, Ma ZL and Jin YX: MiR-146a-5p
inhibits cell proliferation and cell cycle progression in NSCLC
cell lines by targeting CCND1 and CCND2. Oncotarget. 7:59287–59298.
2016.PubMed/NCBI
|
|
23
|
Xu B, Huang Y, Niu X, Tao T, Jiang L, Tong
N, Chen S, Liu N, Zhu W and Chen M: Hsa-miR-146a-5p modulates
androgen-independent prostate cancer cells apoptosis by targeting
ROCK1. Prostate. 75:1896–1903. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pei XH, Lv XQ and Li HX: Sox5 induces
epithelial to mesenchymal transition by transactivation of Twist1.
Biochem Biophys Res Commun. 446:322–327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tseng LM, Hsu NC, Chen SC, Lu YS, Lin CH,
Chang DY, Li H, Lin YC, Chang HK, Chao TC, et al: Distant
metastasis in triple-negative breast cancer. Neoplasma. 60:290–294.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han Y, Zhang L, Wang W, Li J and Song M:
Livin promotes the progression and metastasis of breast cancer
through the regulation of epithelial-mesenchymal transition via the
p38/GSK3β pathway. Oncol Rep. 38:3574–3582. 2017.PubMed/NCBI
|
|
28
|
Okita Y, Kimura M, Xie R, Chen C, Shen LT,
Kojima Y, Suzuki H, Muratani M, Saitoh M, Semba K, et al: The
transcription factor MAFK induces EMT and malignant progression of
triple-negative breast cancer cells through its target GPNMB. Sci
Signal 10: pii: eaak9397. 2017. View Article : Google Scholar
|
|
29
|
van Schooneveld E, Wildiers H, Vergote I,
Vermeulen PB, Dirix LY and Van Laere SJ: Dysregulation of microRNAs
in breast cancer and their potential role as prognostic and
predictive biomarkers in patient management. Breast Cancer Res.
17:212015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McGuire A, Brown JA and Kerin MJ:
Metastatic breast cancer: The potential of miRNA for diagnosis and
treatment monitoring. Cancer Metastasis Rev. 34:145–155. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jia Z, Liu Y, Gao Q, Han Y, Zhang G, Xu S,
Cheng K and Zou W: miR-490-3p inhibits the growth and invasiveness
in triple-negative breast cancer by repressing the expression of
TNKS2. Gene. 593:41–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi SK, Kim HS, Jin T, Hwang EH, Jung M
and Moon WK: Overexpression of the miR-141/200c cluster promotes
the migratory and invasive ability of triple-negative breast cancer
cells through the activation of the FAK and PI3K/AKT signaling
pathways by secreting VEGF-A. BMC Cancer. 16:5702016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen LL, Zhang ZJ, Yi ZB and Li JJ:
MicroRNA-211-5p suppresses tumour cell proliferation, invasion,
migration and metastasis in triple-negative breast cancer by
directly targeting SETBP1. Br J Cancer. 117:78–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang H, Xie J, Zhang M, Zhao Z, Wan Y and
Yao Y: miRNA-21 promotes proliferation and invasion of
triple-negative breast cancer cells through targeting PTEN. Am J
Transl Res. 9:953–961. 2017.PubMed/NCBI
|
